AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionNavellier & Associates Inc
Latest Disclosed Ownership28,305 shares
Latest Disclosed Value $ 6,155,952
Navellier & Associates Inc reports 4.27% decrease in ownership of ABBV / AbbVie Inc.

On May 7, 2026 - Navellier & Associates Inc filed a 13F-HR form disclosing ownership of 28,305 shares of AbbVie Inc. (US:ABBV) valued at $6,156,054 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 29,566 shares of AbbVie Inc.. This represents a change in shares of -4.27% during the quarter. The current value of the position is $6,431,745 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AbbVie COM 00287Y109 28,305 -1,261 -4.27 6,156 -8.88 0.6416
2026-02-03 2025-12-31 13F AbbVie com 00287Y109 29,566 -1,644 -5.27 6,755 -6.52 0.7570
2025-11-06 2025-09-30 13F AbbVie COM 00287Y109 31,210 278 0.90 7,226 25.87 0.7330
2025-08-07 2025-06-30 13F AbbVie COM 00287Y109 30,932 -28 -0.09 5,742 -5.42 0.7112
2025-05-06 2025-03-31 13F AbbVie COM 00287Y109 30,960 -2,473 -7.40 6,070 2.17 0.8385
2025-02-03 2024-12-31 13F AbbVie COM 00287Y109 33,433 -290 -0.86 5,941 -10.78 0.7123
2024-11-12 2024-09-30 13F AbbVie COM 00287Y109 33,723 -1,362 -3.88 6,660 10.67 0.9028
2024-08-08 2024-06-30 13F AbbVie COM 00287Y109 35,085 -408 -1.15 6,018 -6.90 0.7066
2024-05-14 2024-03-31 13F AbbVie COM 00287Y109 35,493 -1,571 -4.24 6,463 12.54 0.7964
2024-02-08 2023-12-31 13F AbbVie COM 00287Y109 37,064 338 0.92 5,744 4.91 0.8605
2023-11-09 2023-09-30 13F AbbVie COM 00287Y109 36,726 7,399 25.23 5,474 38.55 0.9375
2023-08-07 2023-06-30 13F AbbVie COM 00287Y109 29,327 -275 -0.93 3,951 -16.24 0.7695
2023-05-12 2023-03-31 13F AbbVie COM 00287Y109 29,602 -192 -0.64 4,718 -2.01 0.9925
2023-02-02 2022-12-31 13F AbbVie COM 00287Y109 29,794 2,274 8.26 4,815 30.32 0.9811
2022-11-09 2022-09-30 13F AbbVie COM 00287Y109 27,520 -222 -0.80 3,694 -13.06 0.8213
2022-08-12 2022-06-30 13F AbbVie COM 00287Y109 27,742 980 3.66 4,249 -2.05 0.9121
2022-04-29 2022-03-31 13F AbbVie COM 00287Y109 26,762 1,510 5.98 4,338 26.88 0.7376
2022-02-14 2021-12-31 13F AbbVie COM 00287Y109 25,252 -337 -1.32 3,419 23.88 0.4975
2021-10-28 2021-09-30 13F AbbVie COM 00287Y109 25,589 -472 -1.81 2,760 -5.99 0.4161
2021-08-09 2021-06-30 13F AbbVie COM 00287Y109 26,061 1,328 5.37 2,936 9.68 0.4428
2021-05-12 2021-03-31 13F AbbVie COM 00287Y109 24,733 1 0.00 2,677 1.02 0.4814
2021-02-05 2020-12-31 13F AbbVie COM 00287Y109 24,732 -1,001 -3.89 2,650 17.57 0.4798
2020-11-09 2020-09-30 13F AbbVie COM 00287Y109 25,733 -1,030 -3.85 2,254 -14.23 0.4917
2020-08-12 2020-06-30 13F AbbVie COM 00287Y109 26,763 -47 -0.18 2,628 28.63 0.6245
2020-05-13 2020-03-31 13F AbbVie COM 00287Y109 26,810 -3,175 -10.59 2,043 -23.05 0.4801
2020-02-12 2019-12-31 13F AbbVie COM 00287Y109 29,985 448 1.52 2,655 18.69 0.4275
2019-10-16 2019-09-30 13F AbbVie COM 00287Y109 29,537 1,158 4.08 2,237 8.38 0.3702
2019-07-17 2019-06-30 13F AbbVie COM 00287Y109 28,379 -144 -0.50 2,064 -10.22 0.3190
2019-05-15 2019-03-31 13F AbbVie COM 00287Y109 28,523 -881 -3.00 2,299 -15.20 0.3567
2019-01-15 2018-12-31 13F AbbVie COM 00287Y109 29,404 -437 -1.46 2,711 -3.93 0.4609
2018-11-14 2018-09-30 13F AbbVie COM 00287Y109 29,841 123 0.41 2,822 2.51 0.3653
2018-08-06 2018-06-30 13F AbbVie COM 00287Y109 29,718 -333 -1.11 2,753 -3.20 0.3832
2018-05-21 2018-03-31 13F AbbVie COM 00287Y109 30,051 1,612 5.67 2,844 3.42 0.4312
2018-02-12 2017-12-31 13F AbbVie COM 00287Y109 28,439 -5,113 -15.24 2,750 -7.75 0.5142
2017-11-14 2017-09-30 13F AbbVie COM 00287Y109 33,552 -288 -0.85 2,981 21.48 0.5790
2017-08-24 2017-06-30 13F AbbVie COM 00287Y109 33,840 1,085 3.31 2,454 15.00 0.3667
2017-04-21 2017-03-31 13F AbbVie COM 00287Y109 32,755 4,928 17.71 2,134 22.43 0.3110
2017-02-13 2016-12-31 13F AbbVie COM 00287Y109 27,827 5,082 22.34 1,743 21.46 0.2882
2016-10-24 2016-09-30 13F AbbVie COM 00287Y109 22,745 5,722 33.61 1,435 36.15 0.2052
2016-08-03 2016-06-30 13F AbbVie COM 00287Y109 17,023 7,507 78.89 1,054 93.75 0.1573
2016-05-13 2016-03-31 13F AbbVie COM 00287Y109 9,516 9,516 544 0.0706
2013-11-05 2013-06-30 13F/A-1 AbbVie COM 00287Y109 0 -21,210 -100.00 0 -100.00
2013-11-05 2013-03-31 13F/A-1 AbbVie COM 00287Y109 21,210 21,210 865 0.0401
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.